HomeComparePCRIX vs KO

PCRIX vs KO: Dividend Comparison 2026

PCRIX yields 5.79% · KO yields 2.70%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KO wins by $4.8K in total portfolio value· pulled ahead in Year 9
10 years
PCRIX
PCRIX
● Live price
5.79%
Share price
$17.60
Annual div
$1.02
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.3K
Annual income
$836.73
Full PCRIX calculator →
KO
The Coca-Cola Company
● Live price
2.70%
Share price
$76.27
Annual div
$2.06
5Y div CAGR
24.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.1K
Annual income
$4,303.79
Full KO calculator →

Portfolio growth — PCRIX vs KO

📍 KO pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCRIXKO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCRIX + KO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCRIX pays
KO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCRIX
Annual income on $10K today (after 15% tax)
$491.74/yr
After 10yr DRIP, annual income (after tax)
$711.22/yr
KO
Annual income on $10K today (after 15% tax)
$229.58/yr
After 10yr DRIP, annual income (after tax)
$3,658.22/yr
At 15% tax rate, KO beats the other by $2,947.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCRIX + KO for your $10,000?

PCRIX: 50%KO: 50%
100% KO50/50100% PCRIX
Portfolio after 10yr
$31.7K
Annual income
$2,570.25/yr
Blended yield
8.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KO right now

PCRIX
No analyst data
KO
Analyst Ratings
29
Buy
16
Hold
3
Sell
Consensus: Buy
Price Target
$84.88
+11.3% upside vs current
Range: $81.00 — $88.00
Altman Z
5.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCRIX buys
0
KO buys
13
PoliticianChamberTickerTypeAmountDate
Markwayne Mullin🏛 Senate$KO▲ Buy$15,001 - $50,0002025-12-29
Markwayne Mullin🏛 Senate$KO▲ Buy$15,001 - $50,0002025-12-29
Lloyd Doggett🏢 House$KO▲ Buy$1,001 - $15,0002025-12-15
Sheldon Whitehouse🏛 Senate$KO▲ Buy$1,001 - $15,0002025-11-21
Sheldon Whitehouse🏛 Senate$KO▲ Buy$1,001 - $15,0002025-11-21
Julia Letlow🏢 House$KO▲ Buy$1,001 - $15,0002025-11-03
Lisa McClain🏢 House$KO▲ Buy$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$KO▲ Buy$1,001 - $15,0002025-09-25
Val Hoyle🏢 House$KO▼ Sell$1,001 - $15,0002025-09-23
Ro Khanna🏢 House$KO▲ Buy$1,001 - $15,0002025-09-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCRIXKO
Forward yield5.79%2.70%
Annual dividend / share$1.02$2.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%24.3%
Portfolio after 10y$29.3K$34.1K
Annual income after 10y$836.73$4,303.79
Total dividends collected$7.1K$15.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PCRIX vs KO ($10,000, DRIP)

YearPCRIX PortfolioPCRIX Income/yrKO PortfolioKO Income/yrGap
1$11,279$578.52$10,846$335.73+$433.00PCRIX
2$12,678$609.80$11,829$430.64+$849.00PCRIX
3$14,206$640.62$12,988$555.50+$1.2KPCRIX
4$15,871$670.87$14,372$721.34+$1.5KPCRIX
5$17,683$700.48$16,049$944.01+$1.6KPCRIX
6$19,650$729.37$18,114$1,246.74+$1.5KPCRIX
7$21,783$757.49$20,702$1,664.24+$1.1KPCRIX
8$24,092$784.78$24,008$2,249.48+$84.00PCRIX
9← crossover$26,590$811.20$28,317$3,085.19$1.7KKO
10$29,288$836.73$34,065$4,303.79$4.8KKO

PCRIX vs KO: Complete Analysis 2026

PCRIXStock

The investment seeks maximum real return, consistent with prudent investment management. The fund seeks to achieve its investment objective by investing under normal circumstances in commodity-linked derivative instruments backed by a portfolio of inflation-indexed securities and other Fixed Income Instruments. "Fixed Income Instruments" include bonds, debt securities and other similar instruments issued by various U.S. and non-U.S. public- or private-sector entities. It may also invest in leveraged or unleveraged commodity index-linked notes.

Full PCRIX Calculator →

KOConsumer Staples

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Full KO Calculator →
📬

Get this PCRIX vs KO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCRIX vs SCHDPCRIX vs JEPIPCRIX vs OPCRIX vs MAINPCRIX vs PEPPCRIX vs PGPCRIX vs JNJPCRIX vs MCD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.